Trials / Completed
CompletedNCT03265184
Green Coffee Extract Supplementation and Oxidative Stress, Systemic and Vascular Inflammation
Effects of Green Coffee Extract Supplementation on Oxidative Stress, Systemic and Vascular Inflammation in Patients With Metabolic Syndrome: A Randomized Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- National Nutrition and Food Technology Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Metabolic syndrome (Mets) is defined as the collection of risk factors contributing to type 2 diabetes mellitus and cardiovascular disease. Mets is accompanied by oxidative stress and low-grade inflammation. Green coffee is rich in polyphenols called chlorogenic acids (CGA) which possess anti-inflammatory and anti-oxidative characteristics. Thus, we carried out this trial to examine green coffee extract (GCE) effects on oxidative stress, systemic and vascular inflammation in patients having Mets
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | green coffee extract | Patients in treatment group take 400 mg GCE supplements twice a day for tow month |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2017-06-12
- Completion
- 2017-07-18
- First posted
- 2017-08-29
- Last updated
- 2017-08-29
Source: ClinicalTrials.gov record NCT03265184. Inclusion in this directory is not an endorsement.